Results 181 to 190 of about 254,472 (338)

Mechanisms of SCN2A loss of function do not predict presence or phenotype of epilepsy

open access: yesEpilepsia, EarlyView.
Abstract Objective SCN2A loss‐of‐function (LoF) variants are associated with epilepsy (onset age ≥ 3 months), intellectual disability (ID), and autism spectrum disorder (ASD). Despite numerous identified variants and the description of phenotypic subgroups, relationships between Nav1.2 channel dysfunction and clinical phenotypes remain unclear.
Marsha Tan   +23 more
wiley   +1 more source

A Case Report in Using a Laboratory-Based Decision Support Alert for Research Enrollment and Randomization. [PDF]

open access: yesAppl Clin Inform
Barnado A   +8 more
europepmc   +1 more source

ANA [PDF]

open access: yes, 2019
openaire   +1 more source

Freedon study: Real‐life outcomes of cenobamate in different lines of treatment

open access: yesEpilepsia, EarlyView.
Abstract Objectives Cenobamate is an antiseizure medication (ASM) with proven effectiveness in individuals with highly refractory epilepsy. This study investigated the effectiveness and tolerability of cenobamate in different treatment lines and a less refractory setting. Methods This was a multicenter, retrospective, observational study.
Vicente Villanueva   +50 more
wiley   +1 more source

Reply to Benito et al.: Problems in the Cretaceous evolution of the avian palatobasal joint. [PDF]

open access: yesProc Natl Acad Sci U S A
Wilken AT   +4 more
europepmc   +1 more source

Forecasting Electricity Peak Load: Time‐Series Modeling Integrating Economic and Demographic Dynamics—A Case Study From Jordan

open access: yesEnergy Science &Engineering, EarlyView.
Forecasts peak electricity demand in Jordan for grid expansion over the next decade. Introduces a comparative method combining ARIMA, ARIMA‐X, and regression models. Projections show a 41% peak load increase by 2035, reaching around 5300 MW. The findings support capacity planning, pricing strategies, and network expansion.
Rafat Aljarrah   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy